Novartis wins positive EU opinion for SMA gene therapy Itvisma
Go back to Novartis wins positive EU opinion for SMA gene therapy Itvisma| NOVARTIS AG (NYSE: NVS) | Delayed: 153.64 -0.28 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $153.92 | 52 Week High | $89.15 | |||
| Open | $153.93 | 52 Week Low | $69.84 | |||
| Day High | $154.22 | P/E | N/A | |||
| Day Low | $153.12 | EPS | $0.00 | |||
| Volume | 825,270 | |||||
